CCMG
EW icon

Clark Capital Management Group’s Edwards Lifesciences EW Stock Holding History

Clark Capital Management Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38,316
Closed -$2.84M – 438
2024
Q4 		$2.84M Sell
38,316
-36
-0.1% -$2.52K 0.02% 241
2024
Q3 		$2.53M Hold
38,352
– – 0.02% 239
2024
Q2 		$3.54M Sell
38,352
-405
-1% -$35.9K 0.03% 199
2024
Q1 		$3.7M Sell
38,757
-5,887
-13% -$495K 0.03% 203
2023
Q4 		$3.4M Sell
44,644
-241
-0.5% -$16.8K 0.03% 200
2023
Q3 		$3.11M Sell
44,885
-52
-0.1% -$4.18K 0.03% 191
2023
Q2 		$4.24M Sell
44,937
-364
-0.8% -$31.6K 0.04% 175
2023
Q1 		$3.75M Buy
+45,301
New +$3.56M 0.04% 174
2022
Q4 		– Sell
-3,004
Closed -$248K – 359
2022
Q3 		$248K Sell
3,004
-124
-4% -$11.9K ﹤0.01% 322
2022
Q2 		$297K Buy
3,128
+44
+1% +$4.55K ﹤0.01% 294
2022
Q1 		$363K Sell
3,084
-440
-12% -$49.4K ﹤0.01% 322
2021
Q4 		$457K Buy
3,524
+1,393
+65% +$162K 0.01% 293
2021
Q3 		$241K Buy
+2,131
New +$243K ﹤0.01% 319
2021
Q2 		– Sell
-4,140
Closed -$346K – 341
2021
Q1 		$346K Buy
4,140
+117
+3% +$9.89K 0.01% 308
2020
Q4 		$367K Hold
4,023
– – 0.01% 310
2020
Q3 		$321K Buy
4,023
+129
+3% +$10.1K 0.01% 286
2020
Q2 		$269K Sell
3,894
-1,491
-28% -$106K 0.01% 280
2020
Q1 		$339K Sell
5,385
-51
-0.9% -$3.68K 0.01% 251
2019
Q4 		$423K Buy
5,436
+183
+3% +$14.3K 0.01% 264
2019
Q3 		$385K Buy
5,253
+393
+8% +$27.6K 0.01% 262
2019
Q2 		$299K Buy
+4,860
New +$294K 0.01% 265

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Clark Capital Management Group's EW Position: Q1 2025 in Review

Clark Capital Management Group sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 38,316 shares — an estimated $2.84M sold.

Clark Capital Management Group first reported a position in EW in Q2 2019 and held it in 21 quarters. The position peaked at $4.24M in Q2 2023. 1,207 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Clark Capital Management Group reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Clark Capital Management Group sold 38,316 Edwards Lifesciences shares in Q1 2025, an estimated $2.84M.
  • Clark Capital Management Group first reported a position in Edwards Lifesciences in Q2 2019 and held it in 21 quarters.
  • Clark Capital Management Group's Edwards Lifesciences position peaked at $4.24M in Q2 2023.
  • 1,207 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Clark Capital Management Group's 13F filing for Q1 2025, filed 15 May 2025.